Wednesday - April 24, 2024

VEGER Power Inc. Releases ‘ACE100’, a light-weight PD/QC Power Bank with Built in EU/UK Plugs

New York-based, internationally acclaimed Consumer Electronics brand Veger Power Inc. launched ‘ACE100’, the world’s first EU folding plug power bank with PD/QC fast charging technology, designed especially for frequent travelers. ACE100 comes as an addition to their ‘camping power banks’ series. The … Continue reading

Contractor Marketing Firm, A Search Engine Optimization Agency offers Results-Oriented SEO Services for Home Services Businesses in the United States.

Contractor SEO PROS is a full-service digital marketing agency that leverages on proven strategies and tactics to help businesses grow and scale to new heights. It specializes in SEO – search engine optimization, contractor web design, branding, graphics design, content … Continue reading

Spinal Cord Injury Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies – ReNetX Bio, AbbVie, StemCyte, Nipro Corp., Kringle Pharma, Lineage Cell Therapeutics

Delveinsight Business Research LLP As per DelveInsight, the Spinal Cord Injury (SCI) Market size shall grow during the forecast period, owing to the launch of upcoming therapies. Extensive research and development activities of pharmaceutical companies for developing therapies for SCI … Continue reading

Polycythemia Vera Therapeutic Pipeline Analysis – Latest FDA, EMA, PMDA Approvals, Breakthroughs, Clinical Trials, Emerging Therapies, Treatment Algorithm | Key Player- Italfarmaco, Imago BioSciences

Delveinsight Business Research LLP Globally, some of the key companies are involved in developing therapies for Polycythemia Vera; the therapies are under different stages of development and are expected to launch in the coming years. “Polycythemia Vera Pipeline Insight, 2022” … Continue reading

Idiopathic Pulmonary Fibrosis Market to Register Incremental Growth During the Forecast Period 2032, Asserts DelveInsight | Key Companies – Roche, FibroGen, MediciNova, Novartis, Calliditas, Celgene

Delveinsight Business Research LLP The Idiopathic Pulmonary Fibrosis market is expected to increase in the upcoming years owing to the rising prevalent population of Idiopathic Pulmonary Fibrosis (IPF) patients in the 7MM, the launch of emerging therapies, and the active … Continue reading

Contact Dermatitis Pipeline Assessment – Current Therapies, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Key Players – Edesa Biotech, Hapten Sciences

Delveinsight Business Research LLP Till date, there is no approved therapy specific for Contact Dermatitis. The treatment paradigm is mostly similar to that of Atopic Dermatitis. Therefore, the current treatment of Contact Dermatitis is mainly dominated by the use of … Continue reading